Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma
Authors:
Open Access
- 19 August 2015
- journal article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 15 (4) , 7-14
Abstract
Survivin, β-catenin, and p53 are well-known cell-cycle and apoptosis regulators of tumorigenesis. Urothelial carcinomas (UCs) are the most common of the human cancers. Compared to superficial tumors (Ta, CIS, or T1), invasive UCs are important with regard to recurrence, progression, and mortality. Therefore, we examined whether survivin, β-catenin, and p53 could be used as the biomarkers for the early prediction of the invasiveness of UCs and the overall survival of the patients. We investigated the prognostic expressions of those biomarkers in UC (n=147) and in non-muscle invasive UC (NMI-UC) (n=113), using tissue microarray and immunohistochemistry. Spearman's correlation analysis and multivariate Cox regression analyses were used for statistical interpretation. High expressions of β-catenin, survivin, and p53 were associated with a high T stage, recurrence, progression, mortality, low recurrence-free survival, low progression-free survival and low overall survival (p < 0.01). Similar findings were achieved for recurrence and progression in the NMI-UC group, except for mortality. Moreover, a positive correlation was shown between p53 and β-catenin and between p53 and survivin (r=0.221, p < 0.01; r=0.236, p < 0.01, respectively). Survivin, p53, and β-catenin overexpression, as prognostic markers, might suggest that the UCs are biologically aggressive with the poor prognosis. Thus, dysregulation of those these cell-cycle and apoptosis regulators in bladder carcinoma could be used as a molecular marker to determine the best treatment strategy and could contribute to the development of targeted therapies.Keywords
This publication has 32 references indexed in Scilit:
- Survivin regulates the p53 tumor suppressor gene familyOncogene, 2004
- p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder CancerJournal of Clinical Oncology, 2004
- Survivin and molecular pathogenesis of colorectal cancerThe Lancet, 2003
- Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathwayOncogene, 2002
- Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.2002
- Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformationThe EMBO Journal, 2001
- A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.2000
- p53 Expression Predicts Progression and Poor Survival in T1 Bladder TumoursEuropean Urology, 2000
- Dysregulation of Apoptosis in CancerJournal of Clinical Oncology, 1999
- β-catenin — one player, two gamesNature Genetics, 1997